Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines

Journal of Cellular Physiology

Volumn 230, Issue 12, 2015, Pages 2973-2980

  Refolo, Maria Grazia ^a   D'Alessandro, Rosalba ^a   Malerba, Natascia ^a   Laezza, Chiara ^b,c   Bifulco, Maurizio ^d   Messa, Caterina ^a   Caruso, Maria Gabriella ^a   Notarnicola, Maria ^a   Tutino, Valeria ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; BETA CATENIN; CANNABINOID 1 RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; QUERCETIN; RIMONABANT; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; ANTINEOPLASTIC AGENT; CANNABINOID RECEPTOR AGONIST; CNR1 PROTEIN, HUMAN;

ADENOCARCINOMA CELL LINE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CACO 2 CELL LINE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; MTT ASSAY; PRIORITY JOURNAL; PROAPOPTOTIC EFFECT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ADENOCARCINOMA; AGONISTS; CELL MOTION; COLON TUMOR; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; UPREGULATION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CACO-2 CELLS; CANNABINOID RECEPTOR AGONISTS; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; HUMANS; QUERCETIN; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84939863506     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25026     Document Type: Article

References (39)

1. Bifulco M, Malfitano AM, Pisanti S, Laezza C. 2008. Endocannabinoids in endocrine and related tumours. Endocr Relat Cancer 15:391-408.
2. Blázquez C, González-Feria L, Alvarez L, Haro A, Casanova ML, Guzmán M. 2004. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res 64:5617-5623.
3. Carr BI, D'Alessandro R, Refolo MG, Iacovazzi PA, Lippolis C, Messa C, Cavallini A, Correale M, Di Carlo A. 2013. Effects of low concentration of Regorafenib and Sorafenib on human HCC Cell AFP, migration, invasion and growth in vitro. J Cell Physiol 228:1344-1350.
4. De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V. 1998. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci U S A 95:8375-8380.
5. Di Leo A, Messa C, Cavallini A, Linsalata M. 2001. Estrogens and colorectal cancer. Curr Drug Targets Immune Endocr Metabol Disord 1:1-12.
6. Ferraresi R, Troiano L, Roat E, Lugli E, Nemes E, Nasi M, Pinti M, Fernandez MI, Cooper EL, Cossarizza A. 2005. Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radic Res 39:1249-1258.
7. Granado-Serrano AB, Martín MA, Bravo L, Goya L, Ramos S. 2006. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J Nutr 136:2715-2721.
8. Greenhough A, Patsos HA, Williams AC, Paraskeva C. 2007. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. Int J Cancer 121:2172-2180.
9. Grotenhermen F. 2005. Cannabinoids. Curr Drug Targets CNS Neurol Disord 4:507-530.
10. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
11. Joseph J, Niggemann B, Zaenker KS, Entschladen F. 2004. Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol Immunother 53:723-728.
12. Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, Lee MT. 2005. The antitumor activities of flavonoids. In Vivo 19:895-909.
13. Kuo SM. 1996. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 110:41-48.
14. Laezza C, D'Alessandro A, Paladino S, Malfitano AM, Proto MC, Gazzero P, Pisanti S, Santoro A, Ciaglia E, Bifulco M. 2012. Anandamide inhibits the Wnt/b-catenin signalling pathway in human breast cancer MDA MB 231 cells. Eur J Cancer 48:3112-3122.
15. Liang CC, Park AY, Guan JL. 2007. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2:329-333.
16. Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG, Cosenza V, D'argenio G, Scaglione G, Bifulco M, Sorrentini I, Di Marzo V. 2003. Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 125:677-687.
17. Linsalata M, Notarnicola M, Tutino V, Bifulco M, Santoro A, Laezza C, Messa C, Orlando A, Caruso MG. 2010. Effects of Anandamide on Polyamine Levels and cell growth in human colon cancer cells. Anticancer Res 30:2583-2590.
18. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, Bodmer WF, Moyer MP, Riecken EO, Buhr HJ, Hanski C. 1999. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 96:1603-1608.
19. Murakami A, Ashida H, Terao J. 2008. Multitargeted cancer prevention by quercetin. Cancer Lett 269:315-325.
20. Notarnicola M, Messa C, Orlando A, Bifulco M, Laezza C, Gazzerro P, Caruso MG. 2008. Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines. Scand J Gastroenterol 43:66-72.
21. Nuyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. 2004. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 25:647-659.
22. Pacher P, Bátkai S, Kunos G. 2006. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389-462.
23. Park CH, Chang JY, Hahm ER, Park S, Kim HK, Yang CH. 2005. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun 328:227-234.
24. Patsos HA, Hicks DJ, Greenhough A, Williams AC, Paraskeva C. 2005. Cannabinoids and cancer: Potential for colorectal cancer therapy. Biochem Soc Trans 33:712-714.
25. Pertwee RG. 1997. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129-180.
26. Pertwee RG. 2009. Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 156:397-411.
27. Qiu Y, Waters CE, Lewis AE, Langman MJS, Eggo MC. 2002. Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor β. J Endocrinol 174:369-377.
28. Ross JA, Kasum CM. 2002. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu Rev Nutr 22:19-34.
29. Sampson L, Rimm E, Hollman PC, de Vries JH, Katan MB. 2002. Flavonol and flavone intakes in US health professionals. J Am Diet Assoc 102:1414-1420.
30. Santoro A, Pisanti S, Grimaldi C, Izzo AA, Borrelli F, Proto MC, Malfitano AM, Gazzerro P, Laezza C, Bifulco M. 2009. Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon. Int J Cancer 125:996-1003.
31. Sebio A, Kahn M, Lenz HJ. 2014. The potential of targeting Wnt/β-catenin in colon cancer. Expert Opin Ther Targets 18:611-615.
32. Shih H, Pickwell GV, Quattrochi LC. 2000. Differential effects of flavonoid compounds on tumor promoter-induced activation of the human CYP1A2 enhancer. Arch Biochem Biophys 373:287-294.
33. Temraz S, Mukherji D, Shamseddine A. 2013. Potential Targets for Colorectal Cancer Prevention. Int J Mol Sci 14:17279-17303.
34. van Erk MJ, Roepman P, van der Lende TR, Stierum RH, Aarts JM, van Bladeren PJ, van Ommen B. 2005. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr 44:143-156.
35. Wang D, Wang H, Ning W, Backlund MG, Dey SK, DuBois RN. 2008. Loss of cannabinoid receptor 1 accelerates intestinal tumor growth. Cancer Res 68:6468-6476.
36. Woll PS, Morris JK, Painschab MS, Marcus RK, Kohn AD, Biechele TL, Moon RT, Kaufman DS. 2008. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood 111:122-131.
37. Xu X, Liu Y, Huang S, Liu G, Xie C, Zhou J, Fan W, Li Q, Wang Q, Zhong D, Miao X. 2006. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Genet Cytogenet 171:31-38.
38. Xu YX, Hirose Y, Zhou XZ, Lu KP, Manley JL. 2003. Pin1 modulates the structure and function of human RNA polymerase II. Genes Dev 17:2765-2776.
39. Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, Fujioka A, Nishino H, Aoike A. 1990. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260:10-13.